Ocean Biomedical, Inc. Share Price Nasdaq
Equities
OCEA
US67644P1057
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | - | Capitalization | 110M 8.7B |
---|---|---|---|---|---|
Net income 2021 | -62M -4.89B | Net income 2022 | -17M -1.34B | EV / Sales 2021 | - |
Net Debt 2021 | 0.12 9.39 | Net Debt 2022 | 1.19 93.69 | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.8
x | P/E ratio 2022 |
-10.5
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 28.01% |
1st Jan change | Capi. | |
---|---|---|
+16.45% | 122B | |
+21.96% | 116B | |
+25.91% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-15.89% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |